CLL patients harboring PAX5 non‐coding mutations were preferentially associated to the IGHV‐mutated subgroup but were not related to other recurrent CLL mutations, with the exception of del13q14, suggesting that PAX5 non‐coding mutations are early events in the development of the disease. The gene discussed is PAX5; the disease is B-cell chronic lymphocytic leukemia.